Eli Roza, MD
Nephrology · Hagerstown, MDNPI 1184611444
Payments from drug & device makers
Across 610 payments — averaging $129.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$41K
- Vifor Pharma, Inc.$12K
- Boehringer Ingelheim$11K
- Lilly USA, LLC$9K
- ANI Pharmaceuticals, Inc.$630
- Otsuka America Pharmaceutical, Inc.$601
- plus $5K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 130 | $40,791 |
| Vifor Pharma, Inc. | 59 | $11,597 |
| Boehringer Ingelheim | 45 | $10,800 |
| Lilly USA, LLC | 50 | $9,090 |
| ANI Pharmaceuticals, Inc. | 17 | $630 |
| Otsuka America Pharmaceutical, Inc. | 25 | $601 |
| Bayer | 34 | $598 |
| OPKO Pharmaceuticals, LLC | 35 | $562 |
| Amgen(2 entities) | 24 | $497 |
| Novo Nordisk | 25 | $484 |
| Mallinckrodt Hospital Products Inc. | 21 | $426 |
| Akebia Therapeutics Inc | 17 | $367 |
| Calliditas Therapeutics US Inc. | 17 | $330 |
| Travere Therapeutics, Inc. | 19 | $291 |
| Fresenius USA Marketing, Inc. | 16 | $275 |
| Mallinckrodt Enterprises LLC | 6 | $186 |
| Aurinia Pharma U.S., Inc. | 9 | $170 |
| Ardelyx, Inc. | 8 | $165 |
| Novartis | 6 | $153 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $145 |
| GSK | 6 | $122 |
| Pfizer | 6 | $120 |
| Ultragenyx Pharmaceutical Inc. | 3 | $71 |
| Biohaven Pharmaceuticals, Inc. | 3 | $59 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Abbott | 2 | $39 |
| Nxstage Medical, Inc. | 2 | $31 |
| Amarin Pharma, Inc. | 2 | $26 |
| Scpharmaceuticals Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $21 |
| Kyowa Kirin, Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $15 |
| Strongbridge US Inc. | 1 | $12 |
| AbbVie | 1 | $12 |
| Biomerieux Inc | 1 | $10 |
How this compares
$78,843 in reported general payments places this provider in the 90th percentile of 285 nephrology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Hagerstown
- Oscar AdlerHagerstown$224K
- Christopher SperatiBaltimore$1.5M
- Michelle EstrellaBaltimore$1.2M
- Mohamed AttaBaltimore$1.1M
- Chirag ParikhBaltimore$1M
- Mario BelledonnePotomac$715K
- Matthew WeirBaltimore$518K
- Kiran SamindlaFrederick$491K
- Saeed KronfliTakoma Park$463K
- Duvuru GeethaBaltimore$409K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.